Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting

Cardiovascular Revascularization Medicine

Volumn 8, Issue 2, 2007, Pages 84-89

  Barlis, Peter ^a   Horrigan, Mark ^a   Elis, Safari ^a   Chan, Robert ^a   Wong, Michael ^a   Farouque, Omar ^a   Proimos, George ^a   Ajani, Andrew E ^b   Clark, David J ^a  

^a AUSTIN HOSPITAL   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

Author keywords

Drug eluting stents; Left main disease; Percutaneous coronary intervention

Indexed keywords

'TAXUS'; CYPHER; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART BLOOD VESSEL; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL; HUMAN; LEFT CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RESEARCH DESIGN; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34250159866     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2006.11.007     Document Type: Article

References (19)

1. Park S., Kim Y., Lee B., Lee S., Lee C., Hong M., Kim J., Mintz G., and Park S. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
2. Takagi T., Stankovic G., Finci L., Toutouzas K., Chieffo A., Spanos V., Liistro F., Briguori C., Corvaja N., Albero R., Sivieri G., Paloschi R., Di Mario C., and Colombo A. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation 106 (2002) 698-702
3. Tan W., Tamai H., Park S., Plokker H., Nobuyoshi M., Suzuki T., Colombo A., Macaya C., Holmes D., Cohen D., Whitlow P., Ellis S., and ULTIMA Investigators. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 104 (2001) 1609-1614
4. Ellis S., Tamai H., Nobuyoshi M., Kosuga K., Colombo A., Holmes D., Macaya C., Grines C., Whitlow P., White H., Moses J., Teirstein P., Serruys P., Bittl J., Mooney M., Shimshak T., Block P., and Erbel R. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation 96 (1997) 3867-3872
5. Black A., Cortina R., Bossi I., Choussat R., Fajadet S., and Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 37 (2001) 832-838
6. Marso S., Steg G., Plokker T., Holmes D., Park S., Kosuga K., Tamai H., Macaya C., Moses J., White H., Verstraete S., and Ellis S. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment. Am J Cardiol 83 (1999) 1513-1517
7. Agostoni P., Valgimigli M., Van Mieghem C., Rodriguez-Granillo G., Aoki J., Ong A., Tsuchida K., McFadden E., Ligthart J., Smits P., de Jaegere P., Sianos G., Van der Giessen W., De Feyter P., and Serruys P. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol 95 (2005) 644-647
8. Chieffo A., Stankovic G., Bonizzoni E., Tsagalou E., Iakovou I., Montorfano M., Airoldi F., Michev I., Sangiorgi M., Carlino M., Vitrella G., and Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
9. Valgimigli M., van Mieghem C., Ong A., Aoki J., Granillo G., McFadden E., Kappetein A., de Feyter P., Smits P., Regar E., Van der Giessen W., Sianos G., de Jaegere P., Van Domburg R., and Serruys P. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111 (2005) 1383-1389
10. Nashef S., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
11. Moses J., Leon M., Popma J., Fitzgerald P., Holmes D., O'Shaughnessy C., Caputo R., Kereiakes D., Williams D., Teirstein P., Jaeger J., Kuntz R., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
12. Schofer J., Schluter M., Gershlick A., Wijns W., Garcia E., Schampaert E., Breithardt G., and E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
13. Colombo A., Orlic D., Stankovic G., Corvaja N., Spanos V., Montorfano M., Liistro F., Carlino M., Airoldi F., Chieffo A., and Di Mario C. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107 (2003) 2178-2180
14. Stone G., Ellis S., Cox D., Hermiller J., O'Shaughnessy C., Mann J., Turco M., Caputo R., Bergin P., Greenberg J., Popma J., Russell M., and TAXUS-IV Investigators. A polymer based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
15. White H., Assmann S., Sanborn T., Jacobs A., Webb J., Sleeper L., Wong C., Stewart J., Aylward P., Wong S., and Hochman J. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 112 (2005) 1992-2001
16. Arampatzis C., Lemos P., Tanabe K., Hoye A., Degertekin M., Saia F., Lee C., Ruiter A., McFadden E., Sianos G., Smits P., van der Giessen W., de Feijter P., van Domburg R., and Serruys P. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am J Cardiol 92 (2003) 327-329
17. Caracciolo E., Davis K., Sopko G., Kaiser G., Corley S., Schaff H., Taylor H., and Chaitman B. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation 91 (1995) 2335-2344
18. Smith S., Feldman T., Hirshfeld J., Jacobs A., Kern M., King S., Morrison D., O'Neil W., Schaff H., Whitlow P., Williams D., Antman E., Adams C., Anderson J., Faxon D., Fuster V., Halperin J., Hiratzka L., Hunt S., Nishimura R., Ornato J., Page R., and Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
19. Hochman J., Sleeper L., Webb J., Sanborn T., White H., Talley J., Buller C., Jacobs A., Slater J., Col J., McKinlay S., and LeJemtel T. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634